Event Brief
Jun 8, 2026 at 9:04 AM ET
Incyte deal up to $2bn for blood disorder biotech
By The BriefBrief
Incyte agreed a deal worth up to $2bn with a blood-disorder biotech to supplement its pipeline.
WHO: Incyte
WHAT: Agreed a deal worth up to $2bn for a blood-disorder biotech
WHEN: Jun 8, 2026 at 8:40 AM ET
WHERE: Location not specified
WHY: Cause not yet established.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Iraq reopens airspace after Iran halts attacks
Iraq
Jun 8, 2026 at 9:04 AM ET
Iran seeks regional power via strikes on Israel
Iran
Jun 8, 2026 at 9:04 AM ET
Israel claims strike on Iranian petrochemical complex
Middle-East
Jun 8, 2026 at 9:03 AM ET
Oil prices give up gains after Iran ends attacks
World
Jun 8, 2026 at 9:02 AM ET
Page 16223 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
